| 2024-05-14 |
详情>>
业绩披露：
2023年年报每股收益2.16巴西雷亚尔,归母净利润29.74亿巴西雷亚尔,同比去年增长203.99%
|
| 2023-11-15 |
详情>>
股本变动：
变动后总股本69342.40万股
|
| 2023-11-15 |
详情>>
业绩披露：
2023年三季报(累计)每股收益4.09巴西雷亚尔,归母净利润56.40亿巴西雷亚尔,同比去年增长386.36%
|
| 2023-08-15 |
详情>>
业绩披露：
2023年中报每股收益-1.01巴西雷亚尔,归母净利润-13.84亿巴西雷亚尔,同比去年增长1.81%
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益-0.47巴西雷亚尔,归母净利润-6.52亿巴西雷亚尔,同比去年增长-1.45%
|
| 2023-05-01 |
详情>>
业绩披露：
2022年年报每股收益-2.08巴西雷亚尔,归母净利润-28.6亿巴西雷亚尔,同比去年增长-372.88%
|
| 2023-05-01 |
详情>>
业绩披露：
2020年年报每股收益-0.52巴西雷亚尔,归母净利润-6.5亿巴西雷亚尔,同比去年增长-518.22%
|
| 2022-11-10 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.44巴西雷亚尔,归母净利润-19.7亿巴西雷亚尔,同比去年增长-658.68%
|
| 2022-08-12 |
详情>>
业绩披露：
2022年中报每股收益-1.03巴西雷亚尔,归母净利润-14.1亿巴西雷亚尔,同比去年增长-1869.46%
|
| 2022-05-06 |
详情>>
业绩披露：
2022年一季报每股收益-0.47巴西雷亚尔,归母净利润-6.43亿巴西雷亚尔,同比去年增长-314.45%
|
| 2022-04-11 |
详情>>
业绩披露：
2021年年报每股收益0.76巴西雷亚尔,归母净利润10.48亿巴西雷亚尔,同比去年增长261.18%
|
| 2022-03-22 |
股东大会：
将于2022-04-20召开股东大会
会议内容 ▼▲
- 1.review the managers’ accounts, examine, discuss and vote the financial statements, together with the independent auditors' report, for the fiscal year ended on December 31, 2021;
2.examine, discuss and vote the capital budget proposal for the fiscal year ending on December 31, 2022;
3.examine, discuss and vote on the proposed allocation of the net profits for the fiscal year ended on December 31, 2021, and the distribution of dividends;
4.define the number of members for the Company’s Board of Directors;
5.resolve on the independence of the candidates for the positions of independent members of the Company's Board of Directors;
6.elect the members of the Company’s Board of Directors;
7.define the global compensation of the Company’s managers, to be paid by the date of the annual general meeting at which the Company’s shareholders will vote on the financial statements for the fiscal year ending on December 31, 2022.
8.resolve on the rectification and ratification of the global compensation of the Company’s managers relating to the period from May 2021 to April 2022, fixed at the Company’s Annual General Meeting held on April 16, 2021;
9.Resolve on the amendment to article 5 and the consolidation of the Company’s Bylaws, so as to reflect the amount of the capital stock confirmed at the Board of Directors’ Meeting held on March 18, 2022.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-19 |
股东大会：
将于2021-04-16召开股东大会
会议内容 ▼▲
- Annual General Meeting:
1.review the management's accounts, examine, discuss and vote on the management report and the financial statements, together with the independent auditors' report, for the fiscal year ended on December 31, 2020;
2.examine, discuss and vote on the proposed allocation of the losses assessed in the fiscal year ended on December 31, 2020 to the Company accrued losses account;
3.define the global compensation of the Company’s managers, to be paid by the date of the annual general meeting at which the Company’s shareholders shall vote on the financial statements for the fiscal year ending on December 31, 2021.
Extraordinary General Meeting:
1.resolve on the rectification and ratification of the global compensation of the Company's managers relating to the period from May 2020 to April 2021, fixed at the Company's Annual General Meeting held on April 30, 2020;
2.resolve on the absorption of the losses assessed in the fiscal year ended on December 31, 2020 by the capital reserve account related to the premium in the issue/sale of shares of the Company;
3.resolve on the independence of Mrs. Georgia Garinois-Melenikiotou, candidate to the Company's Board of Directors;
4.resolve on the election of Mrs. Georgia Garinois-Melenikiotou to hold office as independent member of the Company’s Board of Directors, for a term of office unified with the other members of the Board of Directors, which will end on the date of the annual general meeting at which the Company’s shareholders shall vote on the financial statements for the fiscal year ending on December 31, 2021;
5.resolve on the update to article 5 of the Company's Bylaws, so as to reflect the amount of the capital stock confirmed at the Board of Directors' Meeting held on March 16, 2021;
6.resolve on the amendment to paragraph 1, article 16 of the Company's Bylaws to provide that a majority of the Board of Directors be composed of external members, having at least one third of independent members;
7.resolve on the amendment to letter “j”, paragraph 4, article 18 of the Company's Bylaws, to exclude the obligation that at least one Co-Chairman of the Board of Directors be a member of the Organizational Development and Personnel Committee;
8.resolve on the amendment to item xxv.in article 20 of the Company's Bylaws, to provide that the Board of Directors shall issue a statement on conducting public offerings for the purchase of shares the subject matter of which are other securities convertible into or exchangeable for shares issued by the Company, in addition to its shares;
9.resolve on the inclusion of new item xxviii.in article 20 of the Company’s Bylaws, to provide that the Board of Directors shall issue a statement on the terms and conditions of corporate restructurings, capital increases and other transactions giving rise to change of control, and decide whether these transactions assure fair and equitable treatment to the Company’s shareholders;
10.resolve on the inclusion of new item xxix.in article 20 of the Company’s Bylaws, to provide that the Board of Directors shall assess and annually disclose who are the independent directors of the Company, as well as inform and justify any circumstances that may jeopardize their independence;
11.resolve on the inclusion of new item xxx.in article 20 of the Company’s Bylaws, to provide that the Board of Directors shall resolve on the transactions with related parties it is empowered to resolve upon, as defined in the corresponding policy of the Company;
12.resolve on the amendment to item xxvi), article 20 and to letter “c”, paragraph 2, article 24 of the Company's Bylaws, to correct the wording and cross-reference;
13.resolve on the restatement of the Company's Bylaws, to reflect the amendments set forth in the items above.
|
| 2020-08-25 |
股东大会：
将于2020-08-27召开股东大会
会议内容 ▼▲
- 1.Approval of the management's proposal for the amendment of Article 5 of the Company's Bylaws to reflect the share capital recorded at the meetings of the Board of Directors held on June 30, 2020 and on July 27, 2020
2.Approval of the management's proposal for the change of the Company's authorized capital, with the consequent amendment of the main section of Article 6 of the Bylaws, so that the share capital can be increased up to the limit of one billion and five hundred million (1,500,000,000) common shares, with no par value, upon a resolution of the Board of Directors, regardless of a Bylaws amendment.
3.Approval of the management proposal so that General Meetings can be installed and chaired by the Company's Corporate Governance Officer in case of absence or impairment of the Co-Chairmen of the Board of Directors and the Executive Chairman of the Board of Directors, with the consequent amendment of Article 11 of the Bylaws.
4.Approval of the management's proposal for the restatement of the Company’s Bylaws to reflect the modifications indicated above
5.If a second call for the EGM needs to be performed, the vote instructions contained in this Ballot may be considered in the event the EGM is held on a second call?
|
| 2020-04-02 |
股东大会：
将于2020-04-30召开股东大会
会议内容 ▼▲
- At the Annual General Meeting:
1.to receive the management accounts, examine, discuss and vote on the management report and the financial statements, accompanied by the independent auditors’ report, for the fiscal year ended on December 31, 2019;
2.to examine, discuss and vote the proposals of allocation of losses assessed in the fiscal year ended on December 31, 2019 to the accrued losses account of the Company;
3.to define the number of members for the Company’s Board of Directors;
4.to resolve on the independence of the candidates to the positions of members of the Board of Directors;
5.to appoint the members of the Company’s Board of Directors, for the unified term of office set forth in the Bylaws, which will be equal to either one (1) year or, in case of approval of the increase in the unified term of office included in the agenda for the Extraordinary General Meeting to be held on the same date, two (2) years;
6.to fix the overall compensation of the Company’s managers, to be paid up to the date of the annual general meeting at which the Company shareholders vote on the financial statements for the fiscal year ending on December 31, 2020.
At the Extraordinary General Meeting:
1.to resolve on the absorption of the losses assessed in the fiscal year ended on December 31, 2019 into the capital reserve account related to the premium in the issue/sale of shares;
2.to resolve on the amendment of the main section and paragraph 2, and the exclusion of paragraph 6, of article 16, the amendment of article 18 and its paragraphs, the amendment of paragraph 3 of article 19 and the inclusion of new item “xxvii” to article 20 of the Company’s Bylaws, to (i) change the unified term of office of the Board of Directors from up to one (1) year to two (2) years; (ii) create the position of Chief Executive of the Group and to specify its attributions; (iii) change and specify the attributions of the Co-Chairmen and of the Executive Chairman of the Board of Directors and; and (iv) implement adjustments to the operation rules and competences of the Board of Directors;
3.to resolve on the amendment of article 21 and its paragraphs, the amendment of item “ii” of article 22, the exclusion of article 23, the amendment of article 24 and its paragraphs and the amendment of the main section, and the inclusion of new item “c”, to article 25 of the Company’s Bylaws, to change the composition and structure of the Executive Board of the Company, in order to create and assign specific roles for the positions of Executive Officer for Latin America, Financial Officer, Investor’s Relations Officer, Corporate Governance Offer and Global Operations and Procurement Officer, and to reflect the creation of the position of Chief Executive of the Group;
4.to resolve on the creation of the Group Operating Committee, in order to assist, advise and provide support to the leadership and management of the interests of the Natura group, as well as to specify its duties, with the respective creation of Subsection IV to Section II of Chapter III of the Company’s Bylaws;
5.to resolve upon the amendment to article 41 and the exclusion of current article 42, sole paragraph, from the Company’s Bylaws, as a result of the Company’s current shareholding structure;
6.to resolve upon the restatement of the Company’s Bylaws, including with the renumbering of articles, to reflect the modifications indicated above, as well as the amendment to article 5 of the Bylaws to state the updated figures for both the capital stock amount and the number of shares.
|